Evidence map›Paper›PMID 24521084›Full record

ArticleMolecular pain2014

Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human: expression, trafficking and possible role in pain.

Tie-Jun Sten Shi, Qiong Xiang, Ming-Dong Zhang, Swapnali Barde, Ylva Kai-Larsen, Kaj Fried, Anna Josephson, Laura Glück, Sergey M Deyev, Andrei V Zvyagin and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecular pain, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Role of HDAC5 Epigenetics in Chronic Craniofacial Neuropathic Pain.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Human Dorsal Root Ganglia.Frontiers in cellular neuroscience · 2019
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Molecular dissection of itch.Current opinion in neurobiology · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 5 countries.

Tie-Jun Sten ShiDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden. Tiejun.Shi@ki.se.
Qiong Xiang
Ming-Dong Zhang
Swapnali Barde
Ylva Kai-Larsen
Kaj Fried
Anna Josephson
Laura Glück
Sergey M Deyev
Andrei V Zvyagin
Stefan Schulz
Tomas Hökfelt
Karolinska Institutet · SEFriedrich Schiller University Jena · DEHarbin Institute of Technology · CNInstitute of Bioorganic Chemistry · RUMacquarie University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSomatostatin (SST) and some of its receptor subtypes have been implicated in pain signaling at the spinal level. In this study we have investigated the role of SST and its sst2A receptor (sst2A) in dorsal root ganglia (DRGs) and spinal cord.

resultsSST and sst2A protein and sst2 transcript were found in both mouse and human DRGs, sst2A-immunoreactive (IR) cell bodies and processes in lamina II in mouse and human spinal dorsal horn, and sst2A-IR nerve terminals in mouse skin. The receptor protein was associated with the cell membrane. Following peripheral nerve injury sst2A-like immunoreactivity (LI) was decreased, and SST-LI increased in DRGs. sst2A-LI accumulated on the proximal and, more strongly, on the distal side of a sciatic nerve ligation. Fluorescence-labeled SST administered to a hind paw was internalized and retrogradely transported, indicating that a SST-sst2A complex may represent a retrograde signal. Internalization of sst2A was seen in DRG neurons after systemic treatment with the sst2 agonist octreotide (Oct), and in dorsal horn and DRG neurons after intrathecal administration. Some DRG neurons co-expressed sst2A and the neuropeptide Y Y1 receptor on the cell membrane, and systemic Oct caused co-internalization, hypothetically a sign of receptor heterodimerization. Oct treatment attenuated the reduction of pain threshold in a neuropathic pain model, in parallel suppressing the activation of p38 MAPK in the DRGs

conclusionsThe findings highlight a significant and complex role of the SST system in pain signaling. The fact that the sst2A system is found also in human DRGs and spinal cord, suggests that sst2A may represent a potential pharmacologic target for treatment of neuropathic pain.

Indexed as

AnimalsDisease Models, AnimalDose-Response Relationship, DrugFemaleFunctional LateralityGanglia, SpinalGene Expression RegulationGlutamate DecarboxylaseGreen Fluorescent ProteinsHumansHyperalgesiaMaleMiceMice, Inbred C57BLMice, TransgenicMiddle AgedCYN 154806Glutamate Decarboxylaseglutamate decarboxylase 1Green Fluorescent ProteinsOctreotideOligopeptidesReceptors, SomatostatinSomatostatinsomatostatin receptor 2, mouse

Identifiers

PMID24521084
PMCPMC3943448
OpenAlexW2125920765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.